Skip to main content

Advertisement

Log in

Risk Factors for Development of Paradoxical Response During Antituberculosis Therapy in HIV-Negative Patients

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The risk factors for development of paradoxical response were studied in a cohort of 104 patients with culture-documented Mycobacterium tuberculosis infection. Paradoxical deterioration occurred in 16 (15.4%) patients (case group) during antituberculosis therapy, involving lungs and pleura (n=4), spine and paraspinal tissue (n=5), intracranium (n=3), peritoneum (n=2), bone and joint (n=1), and lymph node (n=1). The median time from commencement of treatment to paradoxical deterioration was 56 days (range, 20–109 days). Compared with 53 patients without clinical deterioration after antituberculosis therapy (control group), patients with paradoxical response were more likely to have extrapulmonary involvement (62.5% vs. 17.0%; P<0.05) at initial diagnosis, to have lower baseline lymphocyte counts (672±315 cells/μl vs. 1,328±467 cells/μl; P<0.001), and to exhibit a greater surge in lymphocyte counts (627±465 cells/μl vs. 225±216 cells/μl; P<0.05) during paradoxical response. Further studies on lymphocyte subsets and cytokine levels would be useful in understanding the exact immunological mechanisms involved in immunorestitution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, Lau SK, Yuen KY (2002) Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 21:803–809

    Article  CAS  PubMed  Google Scholar 

  2. Al-Majed SA (1996) Study of paradoxical response to chemotherapy in tuberculous pleural effusion. Respir Med 90:211–214

    PubMed  Google Scholar 

  3. Campbell IA, Dyson AJ (1977) Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle 58:171–179

    CAS  PubMed  Google Scholar 

  4. Memish ZA, Mah MW, Mahmood SA, Bannatyne RM, Khan MY (2000) Clinico-diagnostic experience with tuberculous lymphadenitis in Saudi Arabia. Clin Microbiol Infect 6:137–141

    CAS  PubMed  Google Scholar 

  5. Mofredj A, Guerin JM, Leibinger F, Masmoudi R (1996) Paradoxical worsening in tuberculosis during therapy in an HIV-infected patient. Infection 24:390–391

    CAS  PubMed  Google Scholar 

  6. Chien JW, Johnson JL (1998) Paradoxical reactions in HIV and pulmonary TB. Chest 114:933–936

    CAS  PubMed  Google Scholar 

  7. Narita M, Ashkin D, Hollender ES, Pitchenik AE (1998) Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 158:157–161

    Google Scholar 

  8. Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR (2001) Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 120:193–197

    CAS  PubMed  Google Scholar 

  9. John M, French MA (1998) Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy. Med J Aust 1998 169:473–474

    CAS  Google Scholar 

  10. Furrer H, Malinverni R (1999) Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis. Am J Med 106:371–372

    Article  CAS  PubMed  Google Scholar 

  11. Ramdas K, Minamoto GY (1994) Paradoxical presentation of intracranial tuberculomas after chemotherapy in a patient with AIDS. Clin Infect Dis 19:793–794

    CAS  PubMed  Google Scholar 

  12. Crump JA, Tyrer MJ, Lloyd-Owen SJ, Han LY, Lipman MC, Johnson MA (1998) Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin Infect Dis 26:1008–1009

    CAS  PubMed  Google Scholar 

  13. Eyer-Silva WA, Pinto JF, Arabe J, Morais-De-Sa CA (2002) Paradoxical reaction to the treatment of tuberculosis uncovering previously silent meningeal disease. Rev Soc Bras Med Trop 35:59–61

    PubMed  Google Scholar 

  14. Orlovic D, Smego RA Jr (2001) Paradoxical tuberculous reactions in HIV-infected patients. Int J Tuberc Lung Dis 5:370–375

    CAS  PubMed  Google Scholar 

  15. Navas E, Martin-Davila P, Moreno L, Pintado V, Casado JL, Fortun J, Perez-Elias MJ, Gomez-Mampaso E, Moreno S (2002) Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 162:97–99

    Article  PubMed  Google Scholar 

  16. Ramos A, Asensio A, Perales I, Montero MC, Martin T (2003) Prolonged paradoxical reaction of tuberculosis in an HIV-infected patient after initiation of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis 22:374–376

    CAS  PubMed  Google Scholar 

  17. Cheng VC, Woo PC, Lau SK, Cheung CH, Yung RW, Yam LY, Yuen KY (2003) Peripartum tuberculosis: a form of immunorestitution disease. Eur J Clin Microbiol Infect Dis 22:313–317

    CAS  PubMed  Google Scholar 

  18. Valdez LM, Schwab P, Okhuysen PC, Rakita RM (1997) Paradoxical subcutaneous tuberculous abscess. Clin Infect Dis 24:734

    Google Scholar 

  19. Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM (2000) Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 30:882–892

    CAS  PubMed  Google Scholar 

  20. Cheng VC, Yuen KY, Wong SS, Woo PC, Ho PL, Lee R, Chan RM (2001) Immunorestitution diseases in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 20:402–406

    CAS  PubMed  Google Scholar 

  21. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder HL, Binkin N, Dye C, Williams R, Raviglione MC (2001) Global trends in resistance to antituberculosis drugs. N Engl J Med 344:1294–1303

    CAS  PubMed  Google Scholar 

  22. Kam KM, Yip CW, Tse LW, Leung OC, Sin LP, Chan MY, Wong WS (2002) Trends in multidrug-resistant Mycobacterium tuberculosis in relation to sputum smear positivity in Hong Kong, 1989–1999. Clin Infect Dis 34:324–329

    Article  PubMed  Google Scholar 

  23. Ohno H, Koga H, Kuroita T, Tomono K, Ogawa K, Yanagihara K, Yamamoto Y, Miyamoto J, Tashiro T, Kohno S (1997) Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis. Am J Respir Crit Care Med 155:2057–2063

    CAS  PubMed  Google Scholar 

  24. Torres MJ, Criado A, Palomares JC, Aznar J (2000) Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J Clin Microbiol 38:3194–3199

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Y. Yuen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheng, V.C.C., Yam, W.C., Woo, P.C.Y. et al. Risk Factors for Development of Paradoxical Response During Antituberculosis Therapy in HIV-Negative Patients. Eur J Clin Microbiol Infect Dis 22, 597–602 (2003). https://doi.org/10.1007/s10096-003-0998-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-003-0998-z

Keywords

Navigation